Drug targets in malaria parasites

疟疾寄生虫的药物靶点

• 批准号: FF0668705
• 负责人: Prof Geoffrey McFadden
• 金额: $ 110.84万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Federation Fellowships
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-12-15 至 2012-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/FF0668705
• 关键词: Drug; targets; malaria; parasites

Malaria is rampant throughout our Region and hinders the economies of our neighbours reducing regional prosperity and stability. Australian security and aid personnel deployed in the Region contract malaria infections and global warming could bring malaria-carrying mosquitoes south to Sydney. Australia is pre-eminent in malaria research, making lead discoveries in vaccine and drug development. However, we lack crucial resources to study the parasite in the mosquito phase of its life cycle. The Federation Fellowship will create a malaria mosquito facility to redress this crucial gap in our capability. The Fellowship will double as foreign aid investment by enhancing our capacity to protect ourselves as well as supporting our neighbours.

疟疾在我们整个区域肆虐，阻碍了我们邻国的经济，削弱了区域繁荣与稳定。澳大利亚安全和援助人员部署在该地区的合同疟疾感染和全球变暖可能会带来携带疟疾的蚊子南到悉尼。 澳大利亚在疟疾研究方面处于领先地位，在疫苗和药物开发方面取得了领先的发现。 然而，我们缺乏关键的资源来研究蚊子生命周期中的寄生虫。 联合会奖学金将建立一个疟疾蚊子设施，以弥补我们能力中的这一关键差距。该研究金将通过加强我们保护自己和支持我们邻国的能力，加倍作为对外援助投资。